Sentences with phrase «cardiovascular research by»

The research marks another important contribution in cardiovascular research by scientists at Temple's Center for Translational Medicine.

Not exact matches

A Soreon Research report expects the market for wearables, which is still in its infancy, to reach $ 41 billion by 2020, driven by growth in devices aimed at combating diabetes, sleep disorders, and cardiovascular disease.

The results of another clinical trial published in the journal found that high - dose vitamins and minerals did not protect heart attack patients 50 and older from experiencing additional cardiovascular events, though the research was marred by a high dropout rate.

A growing body of research is suggesting that spreading protein consumption throughout the day (starting with breakfast) can improve cardiovascular health, better address muscle maintenance and growth, and help maintain weight by keeping away those «hangries» that happen when your blood sugar drops and energy level tanks (from eating too many carb - heavy foods).

Salt may raise blood pressure by making it harder for the cardiovascular system to juggle the regulation of blood pressure and body temperature, according to new research.

Previous research shows that giving an EPA - DHA supplement to patients with cardiovascular disease reduces their chance of dying from the disease by as much as 20 percent, authors note in the study, but supplementing with margarine didn't seem to cut it.

I work in the Science Policy Department of the Centro Nacional de Investigaciones Cardiovasculares (CNIC), the Spanish national centre for cardiovascular research, which was established by the Spanish ministry of health as a centre of excellence to give impetus to biomedical research in this area.

Intrigued by the medical applications of basic research, she rotated through laboratories in cardiology and cardiovascular disease before settling on Church's group.

«Essentially, they showed me that a large number of traffic incidents are caused by medical conditions while driving, specifically cardiovascular events, such as myocardial infraction and myocardial ischemia,» says Najarian, director of data science at the Michigan Center for Integrative Research in Critical Care.

A study by investigators at Brigham and Women's Hospital (BWH) published this week in PLOS ONE identifies four factors that may account for sex differences in statin therapy among patients with coronary artery disease (CAD), pointing to interventions and additional research that will be needed to help overcome this sex disparity and reduce cardiovascular risk for women.

In the Los Angeles area, recent research, mostly conducted by University of Southern California scientists, has found connections between people living near freeways and asthma, reduced lung function, cardiovascular disease, autism and other health effects.

Another recently published systematic review and meta - analysis by Dr. Sievenpiper's research group found that eating on average one serving a day of beans, peas, chickpeas or lentils can also reduce «bad cholesterol» by five per cent and therefore lower the risk of cardiovascular disease.

A new narrative review authored by Carl Streed Jr., MD, at Brigham and Women's Hospital, published in the Annals of Internal Medicine, discusses how more research is needed to better understand cardiovascular disease (CVD) and CVD risk factors in transgender patients receiving long term cross-sex hormone therapy.

The ISRF - funded research on rats by W.R.F. Pover of the University of Birmingham suggested that gut bacteria help mediate sugar's adverse cardiovascular effects.

The research was prompted by three small, earlier studies that raised concerns about possible adverse cardiovascular outcomes associated with testosterone therapy.

Boehringer Ingelheim is actively involved in research related to such conditions as cardiovascular, metabolic and respiratory diseases, cancer, AIDS, hepatitis C, and diseases mediated by the immune system.

For instance, a finding published by researchers at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, in 2009 said that longer lengths of sitting were directly proportional to an increased risk of death from cardiovascular disease and most causes of death other than cancer.

Even apparently healthy teenagers showed significant improvements in markers which are indicators of cardiovascular health, according to research by the University of Exeter.

More extensive research and new interventions are needed, he adds, if we are to reach the AHA's goal of increasing the proportion of the population in ideal cardiovascular health by 2020.

Much of this research focuses on well - rounded fitness regimens, designed by a physical therapist to suit the patient's goals and often incorporating both cardiovascular and strength training.

Yes, according to a 2010 press release by Wageningen University and Research Centre (WUR) in the Netherlands about a study of the relationship between milk consumption and cardiovascular disease.

A recent joint statement issued by the American Heart Association and the American Diabetes Association concluded that further research into racial and ethnic differences and improved cardiovascular risk - prediction methods in people with type 1 diabetes is needed.

Forthcoming research planned by the group will focus on isolated vitamin D supplementation and indicators of cardiovascular disease in postmenopausal women.

On the research applications front, Dr. Chia Tet Fatt, a young scientist from the Natural Sciences Academic Group at the National Institute of Education, revealed Singapore's very first genetically modified organism (GMO)-- a transgenic resveratrol producing red lettuce for the prevention of cancer and cardiovascular diseases — which was developed by introducing the stilbene synthase gene into a red plant and diverting the precursors into resveratrol synthesis.

Traffic - related air pollution may increase cardiovascular disease risk by lowering levels of high - density lipoprotein (HDL), commonly known as «good» cholesterol, according to new research in the American Heart Association's journal Arteriosclerosis, Thrombosis, and Vascular Biology.

Writing in the journal Neurobiology of Aging, a research team, led by senior author William S. Kremen, PhD, professor of psychiatry and co-director of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine, found that major adverse events in life, such as divorce, separation, miscarriage or death of a family member or friend, can measurably accelerate aging in the brains of older men, even when controlling for such factors as cardiovascular risk, alcohol consumption, ethnicity and socioeconomic status, which are all associated with aging risk.

Yu and her research team were able to determine whether estrogen or testosterone regulated various cardiovascular risk factors by comparing two groups of men whose hormone levels were temporarily changed with combinations of medications.

An alternative approach pioneered by Deepak Srivastava, MD, director of cardiovascular and stem cell research at Gladstone, used genes to convert scar - forming cells in the heart of animals into new muscle that improved the function of the heart.

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

The results were presented Monday at the American College of Cardiology meeting in Washington DC by cardiovascular research fellow Nima Ghasemzadeh, MD..

Led by King's College London, the research shows that people with severe mental illness (SMI), including schizophrenia, bipolar disorder and major depression, have a 53 per cent higher risk for having cardiovascular disease than healthy controls, with a 78 per cent higher risk of developing cardiovascular disease over the longer term.

Other research has found that even two cups a day could lower the risk of cardiovascular disease and stroke by 30 %.

Tabata is a unique form of high - intensity interval - type cardiovascular exercise based on research completed by the Japanese researcher Izumi Tabata, PhD, MD, in the mid-1990s.

According to a research from James J. Di Nicolantonio, a cardiovascular research scientist at St. Luke's Mid-Atlantic Heart Institute in Kansas City, by cutting back on added sugar you cut down risk of heart diseases by three times.

And the famous Framingham Heart study recently added to the huge database of research studies by identifying a relationship between air quality and cardiovascular inflammation.

In my field of cardiovascular disease, air pollution as a trigger for heart attack and death is rarely mentioned but is highly supported by quality research.

With a study this month showing that antioxidant supplements don't protect against cardiovascular disease or cancer, it's refreshing to see so much research showing how a healthy (and delicious) dietary pattern can slash your risk for heart disease and other chronic conditions by up to 50 %.

The research was inspired by studies that looked at the effect of diet and lifestyle changes on other diseases, such as cardiovascular disease, cancer, and HIV.

There is also likely trepidation regarding such a high fat intake — particularly saturated fat — despite mounting evidence even in the medical mainstream that saturated fat intake is not associated with increased risk for cardiovascular disease, and that reductions in carbohydrate intake, in fact, can improve risk for heart disease.55 Promising avenues for research in dietary therapy for AD are hindered by an outdated nutritional paradigm.

In addition, peanuts provide resveratrol, the phenolic antioxidant also found in red grapes and red wine that is thought to be responsible for the French paradox: the fact that in France, people consume a diet that is not low in fat, but have a lower risk of cardiovascular disease compared to the U.S. With all of the important nutrients provided by nuts like peanuts, it is no wonder that numerous research studies, including the Nurses» Health Study that involved over 86,000 women, have found that frequent nut consumption is related to reduced risk of cardiovascular disease.

Additionally, more recent research shows that oxidation of LDL by substances called free radicals increases the risk of cardiovascular illness [19].

Research indicates 2:1 intake of potassium to sodium lowers the risk of death from cardiovascular disease by 50 %.

The popular claim that the presence of resveratrol in red wine is responsible for producing positive cardiovascular effects among French people can't be sustained by a proper medical research.

As a confirmation of the validity of this form of cardiovascular conditioning, extensive research by NASA in the early 1980's led to the conclusion that infrared stimulation of cardiovascular function would be the ideal way to maintain cardiovascular conditioning in American astronauts during long space flights.

Dietary fiber passes through your system undigested, but it provides such vital health benefits that eating enough between the ages of 20 to 59 lowers your risk of developing cardiovascular disease later in life, according to research reported in March 2011 by Northwestern University.

In another research study published in the BMJ, the higher levels of chocolate consumption reduced the risk of cardiovascular disease by 37 % and strokes by 29 %, significantly more than compared to lower levels of chocolate consumption.

«Recent research revealed that cocoa does indeed exert beneficial cardiovascular effects, probably mediated mainly by its polyphenols... This may explain... the potentially beneficial effects on

Such an effect might be even stronger in those with diabetes and (or) cardiovascular disease already,» Dr. Ronald M. A. Henry, of the Cardiovascular Research Institute Maastricht in the Netherlands, told Reuters Health by email.

Not only does research show that pets benefit our cardiovascular health, it also suggests that animal - assisted therapy can alleviate symptoms among those suffering from PTSD by helping patients, often veterans, feel more relaxed and comfortable while improving their overall well - being.

Research conducted by Green et al. (1994) in Israel revealed that between 1976 and 1985, mortality from cardiovascular disease was 50 percent higher in mid-winter than in mid-summer, both in men and women and in different age groups, in spite of the fact that summer temperatures in the Negev, where much of the work was conducted, often exceed 30 °C, while winter temperatures typically do not drop below 10 °C.